Contemporary Management of Malignancies of the Parotid Gland: A State‐of‐the‐Art Review
Advances in the treatment of MPG have improved survival while minimizing treatment toxicity and improving quality of life. Future studies are needed to emphasize personalized oncologic treatment for patients with these rare malignancies.
Authors
- Heath Devin Skinner (ORCID: https://orcid.org/0000-0003-1836-151X)
- Kevin J. Contrera (ORCID: https://orcid.org/0000-0002-2570-1706)
- Diana Bell
- Dan Paul Zandberg (ORCID: https://orcid.org/0000-0002-1002-8301)
- Myers En
- Anthony Tang (ORCID: https://orcid.org/0000-0003-3056-3114)
- Shaum Sridharan (ORCID: https://orcid.org/0000-0001-6049-1508)
- Vanessa Helou
- Jessica L. Geiger
- Matthew E. Spector
- Renata Ferrarotto
Institutions
- Cleveland Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1002/ohn.70170
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- MacroGenics
- Seagen
- Coherus Biosciences